Vertex Pharmaceuticals (Europe) Ltd Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Vertex Pharmaceuticals (Europe) LTD is > 10% Shareholder of CRISPR Therapeutics AG. Currently has a direct ownership of 5.38 Million shares of CRSP, which is worth approximately $215 Million. The most recent transaction as insider was on Dec 27, 2018, when has been sold 27,461 shares (Common Shares) at a price of $24.95 per share, resulting in proceeds of $685,152. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.38M
0% 3M change
0% 12M change
Total Value Held $215 Million

Vertex Pharmaceuticals (Europe) Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 27 2018
BUY
Open market or private purchase
$685,152 $24.95 p/Share
27,461 Added 0.51%
5,380,940 Common Shares
Dec 26 2018
BUY
Open market or private purchase
$317,024 $24.89 p/Share
12,737 Added 0.24%
5,353,479 Common Shares
Dec 24 2018
BUY
Open market or private purchase
$1,610,920 $23.69 p/Share
68,000 Added 1.26%
5,340,742 Common Shares
Dec 21 2018
BUY
Open market or private purchase
$513,514 $22.58 p/Share
22,742 Added 0.43%
5,272,742 Common Shares
VP(

Vertex Pharmaceuticals (Europe) LTD

> 10% Shareholder
London, X0

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP